Your browser doesn't support javascript.
loading
Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
Malamba, Samuel S; Mermin, Jonathan; Reingold, Arthur; Lule, John R; Downing, Robert; Ransom, Ray; Kigozi, Aminah; Hunt, Ben M; Hubbard, Alan; Rosenthal, Philip J; Dorsey, Grant.
Afiliação
  • Malamba SS; Centers for Disease Control and Prevention-Uganda, Global AIDS Program, National Center for HIV, STD and TB Prevention, Entebbe, Uganda. malambas@berkeley.edu
Am J Trop Med Hyg ; 75(3): 375-80, 2006 Sep.
Article em En | MEDLINE | ID: mdl-16968909
ABSTRACT
The purpose of this prospective cohort study was to assess the effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine (SP)-resistant malaria parasites among HIV-uninfected household members. A total of 2,567 HIV-uninfected persons from 605 households were followed and blood specimens were collected each time an episode of Plasmodium falciparum malaria was diagnosed. Study participants were living in households where HIV-infected persons were either taking (exposed) or not taking (unexposed) cotrimoxazole prophylaxis. From all malaria episodes diagnosed, 50% of the specimens were randomly selected and tested for the presence of five key mutations known to mediate resistance to SP (dihydrofolate reductase [dhfr] Asn-108, Ile-51, and Arg-59, and dihydropteroate synthase [dhps] Gly-437 and Glu-540). Plasmodium falciparum isolates were recovered from 163 specimens in the exposed households and 113 specimens in the unexposed households, with similar proportions containing the dhfr triple mutant (37% versus 45%; P = 0.18), the dhps double mutant (64% versus 62%; P = 0.81), and the dhfr/dhps quintuple mutant (30% versus 32%; P = 0.74). The HIV-uninfected persons living with HIV-infected household members taking cotrimoxazole prophylaxis had a lower incidence of malaria (incidence rate ratio [IRR] = 0.64, 95% confidence interval [CI] = 0.50-0.83, P = 0.001) and fewer malaria episodes due to parasites containing the dhfr/dhps quintuple mutant (IRR = 0.61, 95% CI = 0.41-0.91, P = 0.014). Cotrimoxazole prophylaxis taken by HIV-infected persons did not select for SP-resistant malaria parasites among HIV-uninfected household members, and was associated with a lower overall incidence of SP-resistant malaria among household members.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pirimetamina / Sulfadoxina / Infecções por HIV / Combinação Trimetoprima e Sulfametoxazol / Malária Falciparum / Antimaláricos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Am J Trop Med Hyg Ano de publicação: 2006 Tipo de documento: Article País de afiliação: Uganda
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pirimetamina / Sulfadoxina / Infecções por HIV / Combinação Trimetoprima e Sulfametoxazol / Malária Falciparum / Antimaláricos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Am J Trop Med Hyg Ano de publicação: 2006 Tipo de documento: Article País de afiliação: Uganda